Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.56 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.56 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.56 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9763518 | 0.88 | HTR1A (0.52) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9526933 | 0.86 | HTR1A (0.58) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9527346 | 0.86 | ADRA1A (0.65) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL27264163 | 0.83 | DRD4 (0.50) | HTR1AADRA1AADRA1B | |
| SCHEMBL9527840 | 0.83 | HTR1A (0.58) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9528164 | 0.83 | HTR1A (0.58) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9531782 | 0.82 | HTR1A (0.53) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9527001 | 0.81 | ADRA1A (0.63) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9527827 | 0.80 | HTR1A (0.60) | HTR1AADRA1DADRA1AADRA1B | |
| SCHEMBL9528918 | 0.79 | HTR1A (0.59) | HTR1AADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0372305-B1 | PIPERAZINYLALKYL-3(2H)-PYRIDAZINONES, METHOD FOR THEIR PREPARATION AND THEIR USE AS ANTIHYPERTENSIVE AGENTS | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1993-08-04 | — | — | EP | disclosed |
| US-5034391-A | Piperazinylalkyl-3(2H)-pyridazinones and the use thereof as agents lowering blood pressure | CL PHARMA AKTIENGESELLSCHAFT (AT) | 1991-07-23 | — | — | US | disclosed |
| EP-0372305-A1 | Piperazinylalkyl-3(2H)-pyridazinones, method for their preparation and their use as antihypertensive agents | Hafslund Nycomed Pharma Aktiengesellschaft (AT) | 1990-06-13 | — | — | EP | disclosed |